Bayer Schering Pharma

Bayer Schering Pharma

Infobox Company
company_name = Bayer Schering PharmaAG
company_
company_type = Subsidiary
foundation = 1851 "Schering"
2006 "merged"
location = Berlin-Wedding, Germany
key_people = Hubertus Erlen, CEO
num_employees = 26,000 (2004)
revenue = € 10.267 billion (2007)
industry = Pharmaceutical
owner = Bayer
products = Gynaecology & Andrology
Special therapeutics
Diagnostical devices & Nuclear medicine
Oncology
homepage = [http://www.bayerscheringpharma.de/ www.bayerscheringpharma.de]

Bayer Schering Pharma AG is a research-centered pharmaceutical company that was formed by the merger of Schering with Bayer on December 29 2006. The company was originally founded in 1851 by Ernst Schering (1824-1889). The company employs more than 26,000 people in 140 subsidiaries all over the world. The company's headquarters are in Berlin-Wedding, Germany and the forerunner company Schering's annual gross revenue was nearly € 5 billion (2003). They retain the largest German manufacturing facility which is located in Bergkamen.The company focuses on the business areas of gynaecology & andrology, oncology and also special therapeutics, diagnostical devices & nuclear medicine. Schering best-known product is their line of combined oral contraceptive pills.

Through Bayer Healthcare AG Bayer Schering Pharma is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). [cite news|url=http://www.efpia.eu/content/default.asp?PageID=559&DocID=4883|title=The Pharmaceutical Industry in Figures - 2008 Edition |publisher=European Federation of Pharmaceutical Industries and Associations (EFPIA)|pages=49|language=english|accessdate=2008-08-25]

Collaborative Research

In addition to internal research and development activities Bayer Schering Pharma is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox. [Mattes WB (2008), Public consortium efforts in toxicogenomics, Methods Mol Biol. 2008;460:221-38 [http://www.ncbi.nlm.nih.gov/pubmed/18449490] ] cite web|url=http://www.innomed-predtox.com/consortium/members/|title=InnoMed PredTox Member Organizations|accessdate=2008-08-25] The company is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of EFPIA and the European Commission.cite web|url=http://imi.europa.eu/docs/calls01_en.zip|title=IMI Call Topics 2008|last=Innovative Medicines Initiative|work=IMI-GB-018v2-24042008-CallTopics.pdf|publisher=European Commission|accessdate=2008-08-25]

Bayer's Takeover Bid

On March 13, 2006, Merck KGaA announced a €14.6bn bid for Schering [http://inter-x.info/en/web/index.html] . The offer document was due to be issued in early April 2006.

Merck's takeover bid was surpassed by Bayer's $19.5B white-knight bid for Schering on March 23, 2006. In June 2006 Bayer finally bought the majority of shares, over 96%. A domination agreement using the code name "Step One" was used for the take-over. On February 17 2007 the company publicly announced that 1,000 jobs would be cut through voluntary redundancy from the Berlin operations with effect until March 2008.

References

External links


Wikimedia Foundation. 2010.

Игры ⚽ Нужна курсовая?

Look at other dictionaries:

  • Bayer-Schering-Pharma — AG Unternehmensform Aktiengesellschaft Gründung 29. Dezember 2006 Unternehmenssitz Berlin Unternehmensleitung Andreas Fibig …   Deutsch Wikipedia

  • Bayer-Schering-Pharma AG — Unternehmensform Aktiengesellschaft Gründung 29. Dezember 2006 Unternehmenssitz Berlin Unternehmensleitung Andreas Fibig …   Deutsch Wikipedia

  • Bayer Schering Pharma — AG Unternehmensform Aktiengesellschaft Gründung 29. Dezember 2006 Unternehmenssitz Berlin Unternehmensleitung Andreas Fibig …   Deutsch Wikipedia

  • Bayer Schering Pharma AG — Unternehmensform Aktiengesellschaft Gründung 29. Dezember 2006 Unternehmenssitz Berlin Unternehmensleitung Andreas Fibig …   Deutsch Wikipedia

  • Bayer Schering Pharma — Siège social à Berlin Wedding Bayer Schering Pharma est un laboratoire pharmaceutique d origine allemande, division de l entreprise Bayer Santé SAS (Bayer Healthcare) appartenant au groupe chimique Bayer AG. Bayer Schering Pharma développe et… …   Wikipédia en Français

  • Bayer AG — Rechtsform Aktiengesellschaft ISIN DE000BAY0017 Gründung 1863 …   Deutsch Wikipedia

  • Bayer HealthCare Pharmaceuticals — Rechtsform Teilkonzern der Bayer HealthCare AG Gründung …   Deutsch Wikipedia

  • Bayer HealthCare AG — Bayer HealthCare Unternehmensform Aktiengesellschaft Gründung 2003 …   Deutsch Wikipedia

  • Bayer Healthcare — Unternehmensform Aktiengesellschaft Gründung 2003 …   Deutsch Wikipedia

  • Bayer HealthCare — Rechtsform Aktiengesellschaft Gründung 2003 Sitz …   Deutsch Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”